Liang Schweizer Selected Research

BMS 641988

8/2015	Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
8/2009	Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Schweizer Research Topics

Disease

8	Neoplasms (Cancer) 06/2021 - 01/2008
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2008
2	COVID-19 11/2021 - 10/2021
2	Infections 11/2021 - 10/2021
2	Carcinogenesis 02/2014 - 10/2004
1	Bites and Stings (Sting) 06/2021
1	Liver Neoplasms (Liver Cancer) 12/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2015

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 06/2021 - 01/2013
2	AntibodiesIBA 11/2021 - 06/2021
2	bicalutamide (Casodex)FDA LinkGeneric 08/2015 - 08/2009
2	BMS 641988IBA 08/2015 - 08/2009
2	Hormones (Hormone)IBA 08/2009 - 01/2008
2	Androgen Receptors (Androgen Receptor)IBA 08/2009 - 01/2008
2	beta CateninIBA 01/2008 - 10/2004
1	SARS-CoV-2 spike proteinIBA 11/2021
1	enuzovimabIBA 11/2021
1	Monoclonal AntibodiesIBA 11/2021
1	VaccinesIBA 10/2021
1	Doxycycline (Periostat)FDA LinkGeneric 12/2017
1	Small Interfering RNA (siRNA)IBA 12/2017
1	CateninsIBA 12/2017
1	(+)-JQ1 compoundIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Androgen Receptor AntagonistsIBA 08/2015
1	Histone MethyltransferasesIBA 02/2014
1	Androgen Antagonists (Antiandrogens)IBA 08/2009
1	AndrogensIBA 01/2008
1	LigandsIBA 01/2008

Therapy/Procedure

2	Therapeutics 10/2021 - 02/2014
1	Immunotherapy 06/2021
1	Castration 01/2008